The humanistic burden associated with caring for patients with advanced non-small cell lung cancer (NSCLC) in three European countries-a real-world survey of caregivers.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
May 2019
Historique:
received: 20 02 2018
accepted: 09 08 2018
pubmed: 20 8 2018
medline: 10 5 2019
entrez: 20 8 2018
Statut: ppublish

Résumé

This study evaluated the humanistic burden on caregivers of patients with advanced non-small cell lung cancer (aNSCLC) as the disease progresses. Data were drawn from a cross-sectional study of patients with aNSCLC and their caregivers conducted in France, Germany, and Italy between 2015 and 2016. Data were collected by medical chart review and patient and caregiver questionnaires. The EuroQol five-dimension three-level (EQ-5D-3L) was used to evaluate patient and caregiver health status. Caregivers also completed the Work Productivity and Activity Impairment (WPAI) questionnaire and Zarit Burden Interview (ZBI). The population for the analysis consisted of 427 caregivers (mean age 53.5 years; 72.6% female; 54.9% spouse; 36.2% in full-time employment) and 427 matched patients (mean age 66.2 years; 68.6% male). Most (69.5%) patients were receiving first-line therapy for advanced disease. Patients' caregivers provided a mean of 29.5 h of support per week. Significant differences in EQ-5D-3L scores were observed between caregivers of patients receiving first and later lines of therapy in France (0.87 vs. 0.78; p = 0.0055). Among employed caregivers, overall work impairment was considerable and ranged from 21.1% in Germany to 30.4% in France and 29.7% in Italy. Caregivers of patients receiving later lines of therapy in France rated their own health status as significantly worse than did those caring for patients receiving first-line therapy (82.7 vs. 72.9; p = 0.0039). Informal caregivers provided the majority of support for patients with advanced NSCLC and their caregiving activities impose a significant humanistic burden.

Identifiants

pubmed: 30121787
doi: 10.1007/s00520-018-4419-3
pii: 10.1007/s00520-018-4419-3
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1709-1719

Références

Support Care Cancer. 2014 Jan;22(1):181-7
pubmed: 24026981
Cancer Med. 2016 May;5(5):853-62
pubmed: 26860217
BMJ Support Palliat Care. 2017 Dec;7(4):0
pubmed: 28232515
Dement Geriatr Cogn Dis Extra. 2014 Feb 19;4(1):51-64
pubmed: 24711814
Lung Cancer. 2013 Aug;81(2):288-93
pubmed: 23561304
J Bras Pneumol. 2017 Jan-Feb;43(1):18-23
pubmed: 28125154
Cancer. 2017 Mar 1;123(5):832-840
pubmed: 27787881
Support Care Cancer. 2015 Apr;23(4):1035-41
pubmed: 25277959
Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):969-77
pubmed: 26033755
Soc Sci Med. 2011 Oct;73(8):1123-32
pubmed: 21855193
Gerontologist. 1980 Dec;20(6):649-55
pubmed: 7203086
Clin Gastroenterol Hepatol. 2013 Feb;11(2):151-5
pubmed: 22858730
JAMA. 2014 Mar 12;311(10):1052-60
pubmed: 24618967
Aging Ment Health. 2018 Nov;22(11):1424-1431
pubmed: 28812375
Ann Behav Med. 2017 Aug;51(4):519-531
pubmed: 28097515
Eur J Public Health. 2017 Feb 1;27(suppl_1):90-95
pubmed: 28355645
Aging Ment Health. 2006 Mar;10(2):107-11
pubmed: 16517485
J Am Med Dir Assoc. 2016 Jul 1;17(7):626-32
pubmed: 27143237
Eur J Cancer Care (Engl). 2018 Jan;27(1):
pubmed: 28417550
Respir Med. 2008 Oct;102(10):1460-7
pubmed: 18590954
PLoS One. 2012;7(4):e34188
pubmed: 22509278
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Ann Gastroenterol. 2015 Jan-Mar;28(1):124-129
pubmed: 25608915
Health Policy. 2014 Oct;118(1):84-94
pubmed: 25132460
East Asian Arch Psychiatry. 2017 Jun;27(2):71-8
pubmed: 28652500
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
BMJ Open. 2016 Oct 5;6(10):e011694
pubmed: 27707824
J Cancer Res Clin Oncol. 2017 May;143(5):783-791
pubmed: 28215027
Psychooncology. 2013 Nov;22(11):2399-407
pubmed: 23712938
Crit Rev Oncol Hematol. 2012 Jun;82(3):387-401
pubmed: 21741855
Psychooncology. 2017 Jun;26(6):755-762
pubmed: 26790987
Mayo Clin Proc. 2008 Mar;83(3):355-67
pubmed: 18316005
Health Qual Life Outcomes. 2008 Jun 02;6:42
pubmed: 18518961
Qual Life Res. 2015 Dec;24(12):2843-52
pubmed: 26068731
Oncol Nurs Forum. 2013 Jul;40(4):337-46
pubmed: 23803267
Clin J Oncol Nurs. 2012 Dec;16(6):E210-20
pubmed: 23178364
Scand J Public Health. 2018 Jun;46(4):436-447
pubmed: 28823224

Auteurs

R Wood (R)

Adelphi Real World, Bollington, UK. robert.wood@adelphigroup.com.

G Taylor-Stokes (G)

Adelphi Real World, Bollington, UK.

M Lees (M)

Bristol-Myers Squibb, Rueil-Malmaison, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH